Report published on February 12, 2025 Journal of the Association of Cardiovascular Angiography and Intervention Dr. Andrew Goldsweig and colleagues investigated the risk of cardiovascular disease in patients with type…
Inclusion and ethics statement Data informing the GDD modeling estimates for this study, including from LMICs (low- and middle-income countries), were collected between 1980 and 2018 from GDD consortium members…
Livingstone R, Boyle JG, Petrie JR. How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with type 1…
Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ. 2012;345:e5205–e5205. Article PubMed PubMed Central …
Cardiovascular Health: Longevity through Heart-Healthy Living | NHLBI, NIH Skip to main content
World Health Organization Factsheet. Cardiovascular diseases (CVDs). Published 11 June 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 31 August 2023. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM,…
Eating habits aligned with the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet may help lower the risk of cardiovascular disease in adults with type 1 diabetes,…
New research at the Roy Blount NextGen Precision Health Building has uncovered a potential treatment for the underlying cause of cardiovascular disease in people with type 2 diabetes. More than…
Information source Our data source was a nationwide collaborative network that collected electronic health records of hospitalizations and outpatient care from 19 tertiary-level comprehensive medical centers across China between January…
Study setting and patients In this double-blind, randomized trial, adult patients with type 2 diabetes received placebo or dapagliflozin 10 mg once daily for 12 months. The study began on…